Related Experiment Video

Updated: Sep 15, 2025

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

36.5K

First Among Equals: The Case for High-quality Clinical Data in Influenza Vaccines

Jessica E Manning1, Francois Beckers2, Iris de Bruijn2

  • 1Global Clinical Development, Sanofi, Swiftwater, Pennsylvania, USA.

Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|July 15, 2025
PubMed
Abstract

No abstract available in PubMed .

More Related Videos

Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.1K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.2K

Related Experiment Videos

Last Updated: Sep 15, 2025

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers
06:34

An Optimized Hemagglutination Inhibition HI Assay to Quantify Influenza-specific Antibody Titers

Published on: December 1, 2017

36.5K
Expression and Purification of Virus-like Particles for Vaccination
06:17

Expression and Purification of Virus-like Particles for Vaccination

Published on: June 2, 2016

22.1K
Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes
08:52

Use of an Influenza Antigen Microarray to Measure the Breadth of Serum Antibodies Across Virus Subtypes

Published on: July 26, 2019

8.2K

Related Concept Videos

Vaccinations01:51

Vaccinations

45.3K
Overview
45.3K

Articles linked to this work by shared authors, journal, and citation graph.

Small RNA genomics of Aedes aegypti mosquitoes discovers infectious viruses that trigger an RNA interference response.

Nature communications·2026

Serum-antibody Profiling of H3N2-infected Ferrets Using a Combinatorial Phage-display Random Peptide Library.

Journal of molecular biology·2026

Human Immune Response to Influenza Neuraminidase After Vaccination: A Systematic Review.

Influenza and other respiratory viruses·2025

Establishing long-lasting vaccine immunity: insights from mRNA and adjuvanted protein platforms.

NPJ vaccines·2025

Safety and immunogenicity of investigational herpes simplex virus-2 vaccines in adults with recurrent genital infection.

Vaccine·2025

Vaccine Induced Seroreactivity Following Administration of ALVAC-HIV/AIDSVAX®B/E Identified by Common Anti-HIV Test Kits and Algorithms in Thailand.

Open forum infectious diseases·2025

A randomized controlled trial of cefiderocol versus standard therapy for Gram-negative bacterial bloodstream infections: Benefit and risk assessment using DOOR and generalized pairwise comparisons.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Histoplasma Capsulatum Antigen Persistence and Rate of Decay During Treatment of Histoplasmosis Varies by Immune Status.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Reducing Empiric Vancomycin Use in the Pediatric Intensive Care Unit: a Multicenter Study.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Characterizing measles healthcare facility exposures-December 2023-September 2025-New York City.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

Antibodies targeting blood stage antigens of Plasmodium falciparum are associated with resistance to malaria infection and disease.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026

A Multistate Investigation of Serious Adverse Events, including Deaths, following Ceftriaxone Injections, September 2024-August 2025.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us